WO2007100807A8 - Npc1l1 orthologues - Google Patents
Npc1l1 orthologues Download PDFInfo
- Publication number
- WO2007100807A8 WO2007100807A8 PCT/US2007/005037 US2007005037W WO2007100807A8 WO 2007100807 A8 WO2007100807 A8 WO 2007100807A8 US 2007005037 W US2007005037 W US 2007005037W WO 2007100807 A8 WO2007100807 A8 WO 2007100807A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- npc1l1
- orthologues
- set forth
- methods
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e.g., in screening assays, are also set forth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07751771A EP1986489A2 (en) | 2006-02-24 | 2007-02-22 | Npc1l1 orthologues |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77639406P | 2006-02-24 | 2006-02-24 | |
US60/776,394 | 2006-02-24 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007100807A2 WO2007100807A2 (en) | 2007-09-07 |
WO2007100807A3 WO2007100807A3 (en) | 2007-12-27 |
WO2007100807A8 true WO2007100807A8 (en) | 2009-07-23 |
Family
ID=38220019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/005037 WO2007100807A2 (en) | 2006-02-24 | 2007-02-22 | Npc1l1 orthologues |
Country Status (3)
Country | Link |
---|---|
US (2) | US7910698B2 (en) |
EP (1) | EP1986489A2 (en) |
WO (1) | WO2007100807A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7135556B2 (en) * | 2002-07-19 | 2006-11-14 | Schering Corporation | NPC1L1 (NPC3) and methods of use thereof |
US9458422B2 (en) * | 2008-01-25 | 2016-10-04 | University Of Maryland | Composition of matter and method for stimulating the growth of beneficial microorganisms |
WO2009138035A1 (en) * | 2008-05-13 | 2009-11-19 | 中国科学院上海生命科学研究院 | Screening method for medicine of blocking cholesterol absorption based on analyzing subcellular localization of npc1l1 protein |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5561227A (en) | 1991-07-23 | 1996-10-01 | Schering Corporation | Process for the stereospecific synthesis of azetidinones |
US5688787A (en) | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
TW223059B (en) | 1991-07-23 | 1994-05-01 | Schering Corp | |
US5688785A (en) | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
LT3300B (en) | 1992-12-23 | 1995-06-26 | Schering Corp | Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor |
LT3595B (en) | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
EP0707567B1 (en) | 1993-07-09 | 2001-09-12 | Schering Corporation | Process for the synthesis of azetidinones |
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5627176A (en) | 1994-03-25 | 1997-05-06 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
US5633246A (en) | 1994-11-18 | 1997-05-27 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5624920A (en) | 1994-11-18 | 1997-04-29 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5656624A (en) | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
US5618707A (en) | 1996-01-04 | 1997-04-08 | Schering Corporation | Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof |
WO1997016424A1 (en) | 1995-11-02 | 1997-05-09 | Schering Corporation | Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinone |
US5739321A (en) | 1996-05-31 | 1998-04-14 | Schering Corporation | 3-hydroxy γ-lactone based enantionselective synthesis of azetidinones |
US5886171A (en) | 1996-05-31 | 1999-03-23 | Schering Corporation | 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones |
US5756470A (en) | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
WO1999001555A1 (en) | 1997-07-03 | 1999-01-14 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Genes for niemann-pick type c disease |
US6133001A (en) | 1998-02-23 | 2000-10-17 | Schering Corporation | Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone |
US5919672A (en) | 1998-10-02 | 1999-07-06 | Schering Corporation | Resolution of trans-2-(alkoxycarbonylethyl)-lactams useful in the synthesis of 1-(4-fluoro-phenyl)-3(R)- (S)-hydroxy-3-(4-fluorophenyl)-propyl!-4(S)-(4-hydroxyphenyl)-2-azetidinone |
CA2353981C (en) | 1998-12-07 | 2005-04-26 | Schering Corporation | Process for the synthesis of azetidinones |
US6207822B1 (en) | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
CN1249250C (en) | 1999-04-05 | 2006-04-05 | 先灵公司 | Stereoselective microbial reduction for prpn. of 1-(4-fluorophenyl)-3(R)-[3(s)-hydroxy-3-(4-fluorophenyl)propyl)-4(s)-(-4hydroxyphenyl)-2-azetidinone |
US6593078B1 (en) | 1999-04-16 | 2003-07-15 | Schering Corporation | Use of azetidinone compounds |
CA2399776A1 (en) | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
US20030125253A1 (en) | 2000-03-24 | 2003-07-03 | Yoshio Taniyama | Novel protein, process for producing the same and use therof |
AU2001242750A1 (en) | 2000-03-24 | 2001-10-03 | Takeda Chemical Industries Ltd. | Novel protein, process for producing the same and use thereof |
US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
HUP0303915A3 (en) | 2001-01-26 | 2012-12-28 | Merck Sharp & Dohme | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
KR100590342B1 (en) | 2001-03-28 | 2006-06-15 | 쉐링 코포레이션 | Enantioselective synthesis of azetidinone intermediate compounds |
WO2003100094A2 (en) | 2002-05-23 | 2003-12-04 | Devgen Nv | Method for determining the influence of a compound on cholesterol transport |
US7135556B2 (en) | 2002-07-19 | 2006-11-14 | Schering Corporation | NPC1L1 (NPC3) and methods of use thereof |
US20040137467A1 (en) | 2002-07-19 | 2004-07-15 | Schering Corporation | NPC1L1 (NPC3) and methods of use thereof |
US20040132058A1 (en) | 2002-07-19 | 2004-07-08 | Schering Corporation | NPC1L1 (NPC3) and methods of use thereof |
CA2492017A1 (en) * | 2002-07-19 | 2004-01-29 | Schering Corporation | Npc1l1 (npc3) and methods of use thereof |
CN1330667C (en) | 2002-08-06 | 2007-08-08 | 塞诺菲-安万特德国有限公司 | Method for isolating an intestinal cholesterol binding protein |
US20040171073A1 (en) | 2002-10-08 | 2004-09-02 | Massachusetts Institute Of Technology | Compounds for modulation of cholesterol transport |
CA2553769C (en) | 2004-01-16 | 2011-01-04 | Merck & Co., Inc. | Npc1l1 (npc3) and methods of identifying ligands thereof |
EP1789437A4 (en) | 2004-07-30 | 2008-11-05 | Sinai School Medicine | Npc1l1 and npc1l1 inhibitors and methods of use thereof |
-
2007
- 2007-02-22 WO PCT/US2007/005037 patent/WO2007100807A2/en active Application Filing
- 2007-02-22 US US11/710,295 patent/US7910698B2/en not_active Expired - Fee Related
- 2007-02-22 EP EP07751771A patent/EP1986489A2/en not_active Withdrawn
-
2011
- 2011-02-14 US US13/026,763 patent/US8212016B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2007100807A2 (en) | 2007-09-07 |
EP1986489A2 (en) | 2008-11-05 |
US20090098128A1 (en) | 2009-04-16 |
US8212016B2 (en) | 2012-07-03 |
WO2007100807A3 (en) | 2007-12-27 |
US20120084871A1 (en) | 2012-04-05 |
US7910698B2 (en) | 2011-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007133290A8 (en) | Anti-ox40l antibodies and methods using same | |
WO2009058379A3 (en) | Protein scaffolds | |
WO2005118857A3 (en) | Methods and agents for screening for compounds capable of modulating vegf expression | |
WO2007136893A3 (en) | Anti-fgf19 antibodies and methods using same | |
WO2006017538A3 (en) | Hk1-binding proteins | |
WO2008060705A3 (en) | Anti-dll4 antibodies and methods using same | |
WO2007130697A3 (en) | Anti-ephb4 antibodies and methods using same | |
WO2006079076A3 (en) | Yersinia spp. polypeptides and methods of use | |
IL227753A0 (en) | Modified antibody or antibody fragment | |
WO2007006049A3 (en) | Apparatuses, systems, and methods for isolating and separating biological materials | |
BRPI0506679A (en) | Methods of Treating Osteoarthritis with IL-6 Antagonists | |
GB0700909D0 (en) | Novel antigen-binding polypeptides and their uses | |
WO2010011944A3 (en) | Protein screeing methods | |
WO2006066024A8 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
WO2006091734A3 (en) | Compositions and methods for classifying biological samples | |
WO2008048970A3 (en) | Synthetic antibodies | |
WO2006130374A3 (en) | Tweak binding antibodies | |
WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
HK1158700A1 (en) | Methods and compositions for detecting autoimmune disorders | |
WO2007001962A3 (en) | Systems and methods for generating biological material | |
WO2007127506A8 (en) | Anti-ephrinb2 antibodies and methods using same | |
WO2006063028A3 (en) | Immunostimulatory compositions and uses thereof | |
WO2008133705A3 (en) | Assays and devices for identifying pathogens | |
WO2007100807A3 (en) | Npc1l1 orthologues | |
WO2006119736A3 (en) | Pdz-domain modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007751771 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |